Leadoptik
Precision optics for early lung cancer detection.
- Headquarters
- San Jose, California
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- leadoptik.com
- Last Round
- Series ASep 2025
About
LeadOptik (LEADOPTIK) is a medical device company developing precision optics technology for tissue intelligence and lung cancer detection. Its flagship Last Inch Assessment (LIA) technology provides real-time microstructure imaging to guide bronchoscopic biopsies, helping clinicians confirm needle placement in small lesions. The company received FDA clearance in January 2026 and is headquartered in San Jose, California.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account